Mast Therapeutics (MSTX) Tops Q2 EPS by 1c

August 9, 2016 8:20 AM EDT
Get Alerts MSTX Hot Sheet
Trade MSTX Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Mast Therapeutics (NYSE: MSTX) reported Q2 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment